case_images: PMC10978768_01
case_images: Temporal changes in laboratory tests following ceftriaxone-induced immune hemolysis. (A):Temporal changes in complete blood cell following ceftriaxone-induced immune hemolysis; (B):Temporal changes in blood biochemistry following ceftriaxone-induced immune hemolysis; (C):Temporal changes in arterial blood gas following ceftriaxone-induced immune hemolysis. Outpatient blood indices were re-examined on the second, fifth, seventh, 10th, 37th, 42nd, 70th, 77th, 98th, and 105th days after discharge, respectively. WBC: white blood cell, RBC: red blood cell, Hb: hemoglobin, HCT: hematocrit, PLT: platelet count, N: neutrophil, CRP: C-reactive protein, RET: reticulocyte, ALT: alanine aminotransferase, AST: aspartate aminotransferase, TBI: total bilirubin; TBA: total bile acid, LDH: lactate dehydrogenase; CK: creatine kinase, CK-MB: creatine kinase-MB isoenzyme. pH: potential of hydrogen, PO2: partial pressure of oxygen, PCO2: partial pressure of carbon dioxide, BE: base excess.
case_images: fphar-15-1362668-g001.jpg
case_images: PMC10978768_01_fphar-15-1362668-g001.jpg
case_images: F1
case_images: Temporal changes in laboratory tests following ceftriaxone-induced immune hemolysis of the child was shown in Figure 1.
case_images: A timeline of the child's progress from the onset of ceftriaxone-induced immune hemolysis to recovery, discharge, and follow-up. ADRs: adverse drug reactions, ALT: alanine aminotransferase.
case_images: fphar-15-1362668-g002.jpg
case_images: PMC10978768_01_fphar-15-1362668-g002.jpg
case_images: F2
case_images: Child's progress from the onset of ceftriaxone-induced immune hemolysis to recovery, discharge, and follow-up was presented in Figure 2.